1 배진숙, "The role of surgical clips in the evaluation of interfractional uncertainty for treatment of hepatobiliary and pancreatic cancer with postoperative radiotherapy" 대한방사선종양학회 35 (35): 65-70, 2017
2 Sikora SS, "Surgical strategies in patients with gallbladder cancer: nihilism to optimism" 93 : 670-681, 2006
3 Ben-Josef E, "SWOG S0809: a phase II intergroup trial of adjuvant capecitabine and gemcitabine followed by radiotherapy and concurrent capecitabine in extrahepatic cholangiocarcinoma and gallbladder carcinoma" 33 : 2617-2622, 2015
4 Kim WS, "Risk factors influencing recurrence, patterns of recurrence, and the efficacy of adjuvant therapy after radical resection for gallbladder carcinoma" 14 : 679-687, 2010
5 Margonis GA, "Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium" 18 : 872-878, 2016
6 Abramson MA, "Radical resection for T1b gallbladder cancer: a decision analysis" 11 : 656-663, 2009
7 Wang SJ, "Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer" 26 : 2112-2117, 2008
8 이승은, "Practical Guidelines for the Surgical Treatment of Gallbladder Cancer" 대한의학회 29 (29): 1333-1340, 2014
9 Jeong Y, "Postoperative radiotherapy for gallbladder cancer" 34 : 5621-5629, 2014
10 김미영, "Postoperative radiotherapy appeared to improve the disease free survival rate of patients with extrahepatic bile duct cancer at high risk of loco-regional recurrence" 대한방사선종양학회 34 (34): 297-304, 2016
1 배진숙, "The role of surgical clips in the evaluation of interfractional uncertainty for treatment of hepatobiliary and pancreatic cancer with postoperative radiotherapy" 대한방사선종양학회 35 (35): 65-70, 2017
2 Sikora SS, "Surgical strategies in patients with gallbladder cancer: nihilism to optimism" 93 : 670-681, 2006
3 Ben-Josef E, "SWOG S0809: a phase II intergroup trial of adjuvant capecitabine and gemcitabine followed by radiotherapy and concurrent capecitabine in extrahepatic cholangiocarcinoma and gallbladder carcinoma" 33 : 2617-2622, 2015
4 Kim WS, "Risk factors influencing recurrence, patterns of recurrence, and the efficacy of adjuvant therapy after radical resection for gallbladder carcinoma" 14 : 679-687, 2010
5 Margonis GA, "Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium" 18 : 872-878, 2016
6 Abramson MA, "Radical resection for T1b gallbladder cancer: a decision analysis" 11 : 656-663, 2009
7 Wang SJ, "Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer" 26 : 2112-2117, 2008
8 이승은, "Practical Guidelines for the Surgical Treatment of Gallbladder Cancer" 대한의학회 29 (29): 1333-1340, 2014
9 Jeong Y, "Postoperative radiotherapy for gallbladder cancer" 34 : 5621-5629, 2014
10 김미영, "Postoperative radiotherapy appeared to improve the disease free survival rate of patients with extrahepatic bile duct cancer at high risk of loco-regional recurrence" 대한방사선종양학회 34 (34): 297-304, 2016
11 Jarnagin WR, "Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies" 98 : 1689-1700, 2003
12 Jung SJ, "Patterns of initial disease recurrence after resection of biliary tract cancer" 83 : 83-90, 2012
13 Park HS, "Outcome of adjuvant therapy for gallbladder cancer" 79 : 168-173, 2010
14 Glazer ES, "Neither neoadjuvant nor adjuvant therapy increases survival after biliary tract cancer resection with wide negative margins" 16 : 1666-1671, 2012
15 Itoh H, "Magnitude of combination therapy of radical resection and external beam radiotherapy for patients with carcinomas of the extrahepatic bile duct and gallbladder" 50 : 2231-2242, 2005
16 Mitin T, "Limited use of adjuvant therapy in patients with resected gallbladder cancer despite a strong association with survival" 109 : djw324-, 2017
17 Miller G, "Gallbladder carcinoma" 34 : 306-312, 2008
18 Hundal R, "Gallbladder cancer: epidemiology and outcome" 6 : 99-109, 2014
19 Randi G, "Gallbladder cancer worldwide: geographical distribution and risk factors" 118 : 1591-1602, 2006
20 Fong Y, "Evidence-based gallbladder cancer staging: changing cancer staging by analysis of data from the National Cancer Database" 243 : 767-774, 2006
21 Williams TM, "Defining the role of adjuvant therapy: cholangiocarcinoma and gall bladder cancer" 24 : 94-104, 2014
22 Marinelli I, "Clinical target volume in biliary carcinoma: a systematic review of pathological studies" 37 : 955-961, 2017
23 Miyazaki M, "Classification of biliary tract cancers established by the Japanese Society of Hepato-Biliary-Pancreatic Surgery: 3(rd) English edition" 22 : 181-196, 2015
24 Mantripragada KC, "Adjuvant therapy for resected gallbladder cancer: analysis of the National Cancer Data Base" 109 : djw202-, 2016
25 Gold DG, "Adjuvant therapy for gallbladder carcinoma: the Mayo Clinic Experience" 75 : 150-155, 2009
26 Mallick S, "Adjuvant radiotherapy in the treatment of gall bladder carcinoma: what is the current evidence" 28 : 1-6, 2016
27 Sun XN, "Adjuvant radiotherapy for gallbladder cancer: a dosimetric comparison of conformal radiotherapy and intensity-modulated radiotherapy" 17 : 397-402, 2011
28 Mojica P, "Adjuvant radiation therapy is associated with improved survival for gallbladder carcinoma with regional metastatic disease" 96 : 8-13, 2007